Results for "Understanding Pharmaceutical Distribution"
Supply Chain Experts Discuss the Future of the U.S. Pharmaceutical Cold Chain
HDA hosted a LinkedIn Live event exploring the challenges, successes and future of the U.S. pharmaceutical cold chain. The event delved into key findings from the HDA Research Foundation’s report, The Future of the U.S. Pharmaceutical Cold Chain, and featured perspectives from Jeffrey Gainer, Business Process Senior Manager at McKesson, and Rena K. Goins, Executive Director of Global Trade and Distribution at Regeneron. HDA’s Perry Fri, EVP of Industry Relations and Member Services and COO of the HDA Research Foundation, moderated the discussion. Here are three takeaways from the discussion.
Faces of the Supply Chain Highlights How People and Technology Power the Healthcare Supply Chain
In the latest series of HDA’s Faces of the Supply Chain, healthcare distribution sector leaders shared their perspectives on what makes the industry unique, how specialty medications are reshaping distribution models and the role of technology in the future of healthcare distribution.
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.
Julie Galloway Mabeus Joins HDA as Director of Policy
The Healthcare Distribution Alliance (HDA) announces Julie Galloway Mabeus as its new Director of Policy.
Cardinal Health’s Debbie Weitzman and Value Drug Company’s Rick Seipp to Lead HDA Board Of Directors
The Healthcare Distribution Alliance (HDA) announced today that Debbie Weitzman, chief executive officer, pharmaceutical and specialty solutions, Cardinal Health, was elected chair of the association’s Board of Directors. Rick Seipp, president and chief executive officer of Value Drug Company, will serve as vice chair.